Correction: Vol. 30, No. 6

by Pill Pals Customer Service | Jun 11, 2025 | News

Correction: Vol. 30, No. 6 Volume 31, Number 7—July 2025 Altmetrics Click a source for Altmetric details What is the Altmetric Attention Score? The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received....

Hofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk

by Pill Pals Customer Service | Jun 11, 2025 | News

Summary Company Announcement Date: June 11, 2025 FDA Publish Date: June 11, 2025 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential Foodborne Illness – Listeria monocytogenes Company Name: Hofood99 Inc. Brand Name: Product...

FDA approves taletrectinib

by Pill Pals Customer Service | Jun 11, 2025 | News

On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).Full prescribing information for Ibtrozi will be...

Correction: Vol. 30, No. 8

by Pill Pals Customer Service | Jun 11, 2025 | News

Correction: Vol. 30, No. 8 Volume 31, Number 7—July 2025 Altmetrics Click a source for Altmetric details What is the Altmetric Attention Score? The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received....

Bayesian Statistical Analysis (BSA) Demonstration Project

by Pill Pals Customer Service | Jun 11, 2025 | News

C3TI aims to increase the use and understanding of Bayesian statistical methods in simple clinical trial settings across sponsors, CDER clinical reviewers, and CDER statisticians. The Bayesian Statistical Analysis (BSA) demonstration project supports this goal by...

Selective Safety Data Collection (SSDC) Demonstration Project

by Pill Pals Customer Service | Jun 11, 2025 | News

Selective Safety Data Collection (SSDC) offers an innovative approach to facilitate the conduct of large-scale efficacy and safety trials through the purposeful reduction in the collection of certain types of data for drugs or biologics with a well-characterized...